Clinical Trial: A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660848) titled 'A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis' on June 16.

Brief Summary: The purpose of this study is to investigate the efficacy and safety of HRS-4729 injection and HRS9531 injection in adult participants with metabolic dysfunction-associated steatohepatitis after 52 weeks of treatment.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Intervention: DRUG: HRS-4729 Injection

HRS-4729 Injection; high dose, low dose

DRUG: HRS9531 Injection

HRS9531 Injection; high dose, low dose...